Categories Finance

7 days 30 days All time Recent Popular
Quick recap of Zillow’s Q4 earnings report/call $ZG $Z

The Premier Agent business is prob as strong as it has ever been.

Normalized for some accounting nuances, QoQ growth was 20% in Q3 and 27% in Q4.

YoY growth was 13% in 2020 despite a 17% decline in Q2 related to the pandemic.

Reading the tea leaves, it sure sounds like Flex is one of the main drivers of PA revenue acceleration. This is something we talked about in Q3, 2019 when the stock had sold off by 20%+ and was trading in the low 30s


Not gonna claim iBuying is inevitable nor a “good” biz but even skeptics must admit the segment looks more viable today.

And we can all agree iBuying is clearly the superior customer experience compared to the tradition home selling process.


Maybe the most interesting comment made on the call?

The Zestimate will be a live initial offer in some iBuying markets this year 👀
@LaurusLabs #lauruslabs #Q3marketupdates #Q3investorpresentations
Q3fy21/20 in crs
Rev 1288/730 ,up 76%
Ebidta 433/150
PAT 273/73 ,up 274%
EPS 5.1/1.4

Generic API growth 103% yoy
ARVs up 175% yoy
Generic FDF up 47%
Custom synthesis up 63% yoy
Onco API growth 36%


Generic APIs
ARV,Anti-DM,CVS,PPIs,Onco
Commercialized 60+ products
61 DMFs filed

Generic FDF
ARV,Anti-DM,CVS,PPIs,Onco
Filed 26 ANDAs with USFDA
9 final & 8 tentative approvals
Filed 12 dossiers in Canada, 9 in EU ,8 with WHO,2 in
https://t.co/Q35cgK2hvy, 2 in India

Laurus Synthesis
CDMO services for Global pharma
Steroids,hormone mftg
Speciality ingredients in Nutraceuticals,dietary,cosmetics

Commercial scale mfg,clinical phase supplies,Analytics & research

API validation plannd in Unit 5
Optalmic initiated
LSPL-API validatn planned


Revenue breakup in crs
Q3fy21/20
Generic API 731/360
Generic FDF 430/292
Synthesis 127/78

Generic API
ARV 568/214
Onco 64/47
Other 99/99

Generic FDF 430/292

Entered in longterm partnership with leading generic player in EU for contract mfg

Synthesis CDMO 127/78 crs


Synthesis CDMO
Revenue from custom synthesis, strong growth 63% yoy
Total active projects in CDMO stood at 49 in Q3
Partnered Large global pharma & mid ,small biotech companies
Commercial supplies ongoing for 4 products
🧵 Ajax’s own MPP decided to take a non-essential trip outside of the country while our town moved from Red to Lockdown.

I don’t even know where to start on this. Rules for me and not for thee? Financial privilege in action? Getting away from the “plebs” in Ajax? #onpoli 1/x


My family had plans to travel to Europe this summer, but we knew that it had to be postponed to a safer time. We thought of postponing the trip to now, but decided against it until after vaccinations happened and travel advisories are lifted. #onpoli 2/x

And, by the way @RodPhillips01, as someone eligible to vote in Ajax, let me direct you to this big, bold, red text on Global Affairs Canada’s website. #onpoli 3/x


Yes, sometimes there may be an urgent need to leave the country (dying family member or other family emergency), but in a year where Ajacians, and indeed all Ontarians, have made so much sacrifice, this feels like a quintuple slap to the face. #onpoli 4/x

While individuals still go to high-risk, close-contact workplaces during “lockdown” to keep our supply and food chains going, @RodPhillips01 decides to go on vacation. Sounds like another example from a country a few hundred kilometres away. #onpoli 5/x
A THREAD: Groups claiming to be “pro-family” (but really supported by billionaires) are mobilizing against Biden’s proposal of $300 monthly checks to children under 6, and $250 checks to older children.#1


Their claim that these checks would do more harm than good for families is COMPLETELY WRONG. Real experts on family wellbeing patently disagree with them. (See this report, for example. https://t.co/olDXKL3ljq Disclosure: I was on this international panel.)#2

1 in 5 US children now lives in poverty, including almost 1 in 4 Black and Hispanic children. Nearly 1 in 6 children aren’t even getting enough to eat. Monthly checks would ensure a “floor” of income to these children.#3

But it’s more than poor families who need these checks: Almost 1/2 of US households in the United States lost employment income since March 2020, and disproportionately those with children. (No surprise, given widespread school and daycare closures require parents to be home.)#4

Even before COVID, 1/2 of US families had no savings to cover emergency expenses. Their loss of income this year means their spending on children will take a hit. But research shows that whether children get consistent resources critically affects their development.#5
Financial Crisis (1667) avoided by Charles II, via London Goldsmiths' Loans https://t.co/UxtABIpH2n via @old_currency_ex

Coining and Debasement in Henry's Reign
https://t.co/bGitKkj7wl via @wordpressdotcom

When Henry VIII and Francis I Spent $19 Million on an 18-Day Party

England's Unwanted Reformation https://t.co/n1a0u1DzNB via @YouTube

Unusual Historicals: Money Matters: The Country Without a Currency https://t.co/gGGHOFG9rk
Did you catch our thread on the expanding reach of US company Palantir into UK public institutions? £91m+ awarded to the controversial Silicon Valley data-analytics outfit across government. Let's take a closer look at their work with the NHS...


examined the NHS contracts Palantir won under Covid19, trying to find out what aspects of our health data this private company has been given access to. But we couldn’t find out - key parts of the contracts are redacted.


At least £25.4m in contracts have been awarded to Palantir from UK Health Services. Their latest (Dec 2020) was worth up to £23m for them to continue deploying their Foundry data management platform within the NHS until

Foundry claims it can ‘source, connect, and transform’ data to ‘make operations analytical and analytics operational.’ It’s a big-data system that, in an NHS context, analyses patient data. More specifically, your

Palantir won their first NHS contract for just £1, supporting the COVID-19 datastore (Mar-June 2020); then a £1m, 4 month extension for the same work; then £908k for aiding the Test & Trace system (June-Sep